Imperial College London Featured PhD Programmes
University of Kent Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
The Hong Kong Polytechnic University Featured PhD Programmes
"therapy"×
10 miles

therapy PhD Projects, Programs & Scholarships

We have 181 therapy PhD Projects, Programs & Scholarships

  • "therapy" ×
  • clear all
Order by 
Showing 1 to 10 of 181
  Integrative computational analysis of molecular and clinical data to dissect heterogeneity of therapy response in sarcomas
  Dr P Huang, Dr M Cheang, Dr A Sadanandam
Application Deadline: 17 November 2019

Funding Type

PhD Type

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard
Applications accepted all year round

Funding Type

PhD Type

Targeted therapy has had profound impact on outcomes for cancer patients.
  Therapy-induced senescence and stemness in ovarian cancer
  Prof R. Pearson, Dr K Chan
Applications accepted all year round

Funding Type

PhD Type

Cellular senescence is a stress response characterized by a robust cell cycle arrest and is a brake for malignant transformation.
  Characterisation and preclinical evaluation of a fibroblast-activating protein (FAP) targeted TRUCK CAR T-cell therapy for malignant pleural mesothelioma (MPM)
  Dr A Klampatsa, Prof A Melcher, Prof C Isacke
Application Deadline: 17 November 2019

Funding Type

PhD Type

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.
  Patient experience of the Mesothelioma Stratified Therapy Trial (MiST): a qualitative study
  Prof A Tod, Dr B Taylor
Applications accepted all year round

Funding Type

PhD Type

This PhD provides a unique opportunity for a student to conduct a qualitative patient experience health services research study within a complex stratified clinical trial for people with malignant mesothelioma (MM), the Mesothelioma Stratified Therapy Trial (MiST).
  Advanced functional MRI for the characterisation of paediatric glioma and its response to therapy
  Dr S Robinson, Dr C Jones
Application Deadline: 17 November 2019

Funding Type

PhD Type

The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes. We are committed to attracting and developing the best minds in the world to join us in our mission—to make the discoveries that defeat cancer.
  Functional and –omics investigation of neutrophil activation in rheumatoid arthritis
  Dr HL Wright, Prof RJ Moots, Dr M Phelan
Applications accepted all year round

Funding Type

PhD Type

Neutrophils are key effector cells in the pathogenesis of autoimmune diseases such as rheumatoid arthritis (RA), systemic lupus erythematosus and vasculitis.
  Central Nervous system Gene therapy to treat obesity Bardet-Biedl Syndrome (BBS). Analysis of the BBS brain development
  Dr V Hernandez
Applications accepted all year round

Funding Type

PhD Type

Bardet-Biedl syndrome (BBS) is a debilitating, often life-limiting heritable multisystem disorder caused by dysfunction of non-motile cilia (ciliopathy).
  Transcriptional heterogeneity and resistance to therapy in prostate cancer
  Dr D. Goode
Applications accepted all year round

Funding Type

PhD Type

Androgen deprivation therapy (ADT) is a standard treatment for prostate cancer that works well in many cases but rapidly fails in others.
  (MRC DTP) Predicting failure of methotrexate therapy in rheumatoid arthritis patients: statistical approaches to multiple outcomes and repeated observations
  Dr J Sergeant, Dr G P Martin, Prof K Hyrich, Dr S Verstappen
Application Deadline: 15 November 2019

Funding Type

PhD Type

Most patients with rheumatoid arthritis begin treatment with the drug methotrexate (MTX). MTX is cheap and is effective for many patients, but does not work for everyone.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.